Skip to main content

Prepare for new retirement plan reporting and audit methodology changes

two business men talking

The U.S. Department of Labor, Internal Revenue Service and Pension Benefit Guaranty Corporation released changes to the 2023 Form 5500 and Form 5500-SF on Feb. 23. The revisions incorporate statutory amendments to ERISA and the Internal Revenue Code enacted as part of the SECURE Act for multiple-employer plans and groups of plans.

They also made changes that are “intended to improve reporting of certain plan financial information regarding audits and plan expenses and enhance the reporting of certain tax qualification and other compliance information by retirement plans.”

Of particular note is a change in the participant-counting methodology for determining eligibility for simplified reporting alternatives available to “small plans” (generally plans with fewer than 100 participants). 

Under the current methodology, an audit is required for all plans whose total number of participants with plan accounts as of the beginning of the plan year, combined with the number of participants who are active but chose not to have contributions made under a qualified cash or deferred arrangement (and do not have an account balance) equals or exceeds 100.

The revisions will now only use the total number of participants with plan accounts as of the beginning of the year to determine whether a typically costly and time-consuming audit is required.

What does this mean?

Plans with 100 or more active employees but low to moderate participation rates may find welcome relief from the annual audit requirement. Additionally, plans that are able to process small plan cash-outs timely (under $7,000, after the passage of SECURE 2.0), could land below the threshold of requiring an audit.

While this change will not be in effect until next year’s filing season, employers can prepare by reviewing their 2022 data and ensuring that distributions are processed timely during 2023.

Please reach out to HANYS Benefit Services to discuss how we can help. For more information about retirement plans, our services and products, contact us online or call 800.388.1963.


HANYS Benefit Services is a marketing name of Healthcare Community Securities Corp., member FINRA/SIPC, and an SEC Registered Investment Advisor. This material has been prepared for informational purposes only and is not intended to provide, and should not be relied on for, tax, legal or accounting advice. The information in this piece is not a recommendation to invest nor should it be relied upon as instruction to invest.

Popular posts from this blog

SECURE 2.0 Discussion Series: Session Two

The retirement industry has been buzzing since the SECURE 2.0 Act was signed into law last December. This new, comprehensive legislation has sparked a lot of discussion. As with any major reform, it will take time for the industry to fully adapt and understand all its implications. Following our April 11 webinar on the first three months of the industry’s response, our team reconvened to discuss some of what we have heard from our client and vendor partners and to respond to some of the great questions we heard from attendees. Panel participants included the following HBS team members: Noah Buck, Christina Bauer-Dobias, Sean Bayne, Vincent Bocchinfuso and Kathleen Coonan. The Discussion SB – Throughout the webinar, I wanted to stress two things: 1) confusion about where to start and what is expected from plan sponsors is normal; and 2) even more than three months in, this is a developing situation and people should expect changes as time goes on. With those in mind, engagement through

SECURE 2.0 Discussion Series: Session One

SECURE 2.0 provisions: What we know and what’s still up in the air The SECURE 2.0 Act, signed into law in late December 2022, has factored heavily in retirement industry discourse since the final legislation was published. As with any legislation of this depth and breadth, there’s a lot to digest and the industry takes time to adjust. Our team of experienced advisors recently met to discuss some of the more nuanced provisions of the legislation, such as changes to Roth contributions, and what they could mean for plan sponsors. Panel participants included the following HBS team members: Noah Buck, Christina Bauer-Dobias, Sean Bayne, Vincent Bocchinfuso and Kathleen Coonan. Highlights of our panel’s conversation below should serve to help guide plan sponsor thinking. On Roth employer contributions NB – In addition to deferring pre-tax or Roth, plan sponsors can now allow employer contributions to be classified as Roth, is that right? VB – Correct. This is immediately available to plan s

What you should know about biosimilars

Rapidly increasing healthcare costs will likely continue to impact employers for the foreseeable future. As a result, many employers are considering strategies to manage these costs, including rising prescription drug costs. The introduction of biosimilar drugs as an alternative to biologics may bring value to healthcare by offering cost savings and increasing employee access to necessary medications. While biosimilars can potentially combat rising prescription drug costs, employers will need to learn more about them before considering how their health plans can accommodate these newer drugs. This article explores biosimilar drugs and ways employers can promote or manage their use. What are biosimilars? The European Medicines Agency defines a biosimilar as “a biological medicine highly similar to another already approved biological medicine.” It is produced from living organisms — humans, animals or microorganisms, meaning they aren’t created from synthesized chemicals. They are also